NEW YORK ─ Recuro Health on Wednesday announced a $15 million Series A financing to support ongoing acquisitions and expand marketing, among other uses.
Arch Venture Partners led the financing with support from current seed round investors OLSF Ventures, Cortado Ventures, 1843 Capital, and Sage Venture Partners.
Richardson, Texas-based Recuro said its virtual health platform consists of a suite of digital solutions for primary care and behavioral health, including at-home testing and genetic screening, which allow patients to interact with physicians, receive personalized care, and monitor their own health.
The company, launched in March, said in a statement that its COVID-19 rapid testing solution "has generated wide receptivity" among federal and state governments and corporate healthcare decision-makers.